NASDAQ:RNAC | Free Cash Flow | Cartesian Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2014-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$22.14M$27,000.00-$22.16M
2025-12-31-$17.71M$492,000.00-$18.2M
2025-03-31-$23.11M$1.08M-$24.18M
2024-12-31-$7M$705,000.00-$7.71M
2024-03-31-$15.92M$602,000.00-$16.52M
2023-12-31-$23.29M$64,000.00-$23.35M
2023-03-31-$8.77M$130,000.00-$8.9M
2022-12-31-$11.85M$211,000.00-$12.06M-204.65%
2022-03-31-$11.86M$455,000.00-$12.32M-42.81%
2021-12-31-$31.46M$278,000.00-$31.74M-259.32%
2021-03-31-$12.13M$25,000.00-$12.16M
2020-12-31-$7.25M$190,000.00-$7.44M
2020-03-31-$11.7M$135,000.00-$11.83M
2019-12-31-$12.88M$37,000.00-$12.91M
2019-03-31-$20.24M$0.00-$20.24M
2018-12-31-$12.75M$368,000.00-$13.12M
2018-03-31-$13.41M$192,000.00-$13.6M
2017-12-31-$12.66M$149,000.00-$12.81M
2017-03-31-$15.32M$58,000.00-$15.37M
2016-12-31$1.48M$108,000.00$1.37M
2016-03-31-$10.17M$143,000.00-$10.31M
2015-12-31-$7.64M$132,000.00-$7.77M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$73.94M$5.45M-$79.4M
2024-12-31-$23.67M$9.09M-$32.77M
2023-12-31-$51.16M$206,000.00-$51.37M
2022-12-31-$31.63M$1.2M-$32.83M-92.80%
2021-12-31-$60.38M$1.09M-$61.47M
2020-12-31$34.88M$815,000.00$34.07M
2019-12-31-$51.44M$47,000.00-$51.48M
2018-12-31-$59.16M$884,000.00-$60.05M
2017-12-31-$52.03M$733,000.00-$52.76M
2016-12-31-$19.76M$586,000.00-$20.34M
2015-12-31-$22.46M$1.16M-$23.63M
2014-12-31-$12.69M$227,000.00-$12.91M